Tanvex BioPharma, Inc. is a pharmaceutical company engaged in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. Its biosimilars target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. The company also provides contract development and manufacturing services for biological medicines. Founded in 2011, it is headquartered in George Town, the Cayman Islands.